Insider · CIK 0001368626

Hall James G

Reports to the SEC for 2 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001368626

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director, Chief Executive Officer	AAward	+75K sh	—	—	276,096
2023-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	201,096
2022-08-11	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non-Qualified Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	$11.31	+$1.7M	150,000
2022-08-11	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)A Award	Director, Chief Executive Officer	AAward	+45K sh	$11.31	+$509K	45,000
2022-08-05	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director, Chief Executive Officer	FTax Payment	−3,060 sh	—	—	51,096
2022-08-05	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director, Chief Executive Officer	AAward	+10K sh	$10.42	+$104K	54,156
2022-08-05	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−10K sh	$10.42	−$104K	0
2022-07-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non-Qualified Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+49.8K sh	—	—	49,755
2022-07-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Incentive Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+10.2K sh	—	—	10,245
2021-07-27	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non-Qualified StockOption (right to buy)A Award	Director, Chief Executive Officer	AAward	+66.8K sh	—	—	66,763
2021-07-27	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Incentive Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+8,237 sh	—	—	8,237
2021-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,625 sh	$11.82	+$66.5K	46,721
2021-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director, Chief Executive Officer	FTax Payment	−2,565 sh	$11.82	−$30.3K	44,156
2021-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−5,625 sh	—	—	0
2021-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−3,574 sh	—	—	0
2021-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,629 sh	$11.82	−$19.3K	41,096
2021-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+3,574 sh	$11.82	+$42.2K	42,725
2021-04-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$10.62	+$106K	39,151
2020-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Incentive Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+7,636 sh	—	—	7,636
2020-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Incentive Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+7,636 sh	—	—	7,636
2020-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non-Qualified Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+44.9K sh	—	—	44,864
2020-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)A Award	Director, Chief Executive Officer	AAward	+3,574 sh	—	—	3,574
2020-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non-Qualified Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+44.9K sh	—	—	44,864
2020-07-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)A Award	Director, Chief Executive Officer	AAward	+3,574 sh	—	—	3,574
2020-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−25K sh	—	—	0
2020-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+25K sh	$10.84	+$271K	36,757
2020-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director, Chief Executive Officer	FTax Payment	−7,606 sh	$10.84	−$82.4K	29,151
2020-01-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Incentive Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+17.9K sh	$10.12	+$181K	100,000
2020-01-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonqualified Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+82.1K sh	$10.12	+$831K	82,100
2019-08-05	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)A Award	Director, Chief Executive Officer	AAward	+10K sh	—	—	10,000
2019-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,000 sh	$9.42	+$47.1K	13,268
2019-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,511 sh	$9.42	−$14.2K	11,757
2019-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−5,000 sh	—	—	0
2019-05-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+7,000 sh	$9.66	+$67.6K	10,475
2019-05-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director, Chief Executive Officer	FTax Payment	−2,207 sh	$9.66	−$21.3K	8,268
2019-05-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−7,000 sh	—	—	0
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+9,045 sh	—	—	9,045
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonqualified Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+13.6K sh	$14.35	+$195K	118,593
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,625 sh	—	—	5,625
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+7,000 sh	—	—	7,000
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Incentive Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+3,282 sh	$14.35	+$47.1K	121,875
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,525 sh	$13.65	−$20.8K	3,475
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,000 sh	$13.65	+$68.3K	5,000
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−5,000 sh	—	—	0
2017-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Incentive Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+75K sh	$14.00	+$1.05M	75,000
2017-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+25K sh	—	—	25,000
2006-07-10	LIFECORE BIOMEDICAL INCA Award	VP Technical Operations	AAward	+3,500 sh	—	—	3,500
2006-07-10	LIFECORE BIOMEDICAL INCStock Option (Right to Buy)A Award	VP Technical Operations	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Jun 54
Hall James G0001628280-23-020841
SEC(opens sec.gov)
Aug 154
Hall James G0001628280-22-022949
SEC(opens sec.gov)
Aug 84
Hall James G0001628280-22-021699
SEC(opens sec.gov)
Jul 184
Hall James G0001628280-22-019061
SEC(opens sec.gov)
Jul 284
Hall James G0001593968-21-001897
SEC(opens sec.gov)
Jul 264
Hall James G0001593968-21-001872
SEC(opens sec.gov)
Apr 154
Hall James G0001593968-21-001117
SEC(opens sec.gov)
Jul 284/A
Hall James G0001593968-20-001673
SEC(opens sec.gov)

Companies

Address

C/O LANDEC CORPORATION 3603 HAVEN AVENUE

MENLO PARK, CA, 94025